Thus, the reduction of MT1-MMP expression provides a molecular mechanism for IDV anti-angiogenesis effect, rendering this anti-HIV drug a promising antagonist of the formation of new blood vessels which accompanies CIN evolution into CC. Here, MMP14 is linked to cervical squamous intraepithelial neoplasia.